BioResearch
First IND Application Filed for RNAi-Based Drug
The developer of a new drug candidate for the treatment of wet age-related macular degeneration (wet AMD), based on RNA interference (RNAi), has filed an investigational new drug application (IND) to initiate phase I clinical trials. More...23 Aug 2004
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
In Other News
Overactive Brain Circuit Faulted for Depression
European Young Investigator Award
Gene Therapy Reverses Muscular Dystrophy in Mice
Genomic Analysis Reveals Streptococcal Diversity
Cord Blood Stem Cells Differentiate into Various Tissues
Large-Scale Genetic Study of Diabetes
Surprising Cause Found of Spinal Cord Injury
Sensitive Profiling Technique Detects DNA Variations
Alliance to Develop Products from Rainforest Plants
Key Modulator of Inflammation Identified
H pylori Adherence Linked to Blood Group Antigens
Potential for Metastasis May Be Detected Early
Carbohydrate Aids Mabs in Killing Cancer Cells
Genetic Signatures Define Leukemia Risk Categories
Vaccine for Lung Cancer Shows Promise
Patent Protects DNA Display Technology
Drug Developer Interested in Hedgehog Pathway Suppressor
Chromatin Array Technology Pinpoints Gene Activity
Investigational Drug for Prostate Cancer Very Promising
RNAi Gene Therapy for Neurodegenerative Disorders
Virus Linked to Aggressive Breast Cancers
Agilent to Be Exclusive Marketer of CyberLab
RNAi Technology Silences Gene that Causes ALS
BioResearch brings the latest research news on the genome, proteome, metabolome, on drug discovery, and therapeutics. Biotech researchers, lab administrators, technologists, drug manufacturers, and suppliers can find the latest research news and information related to their fields of endeavor here.